ORGO:NASDAQ, Organogenesis Holdings Inc.

ORGO stock overview

Organogenesis Holdings Inc. (ORGO:NASDAQ) closed at $1.02 on October 19, 2026, up 2.03% on the day. The stock trades 85.6% below its 52-week high of $7.08 and 9.8% above its 52-week low of $0.929. Over the past year, it lost 75.0%. Organogenesis Holdings Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$1.02
Day change
+2.03%
Volume
989,102
Average volume
757,056
Market cap
131M+
52-week range
$0.929 – $7.08
50-day average
$1.53
200-day average
$2.54

Price action over the past year

In 252 trading sessions since October 17, 2025, ORGO closed higher on 94 days (37%). Its best day was November 7, 2025 (+44.73%) and its worst was August 7, 2026 (-22.82%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

ORGO news

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc, formerly Avista Healthcare Public Acquisition Corp is a regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets.

Similar stocks

Find more stocks like ORGO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.